Consistently, in amyloid-deficient melanoma cells, ROCK inhibition decreased the level of YAP activation, but the administration of rPMEL amyloid fibrils significantly increased the expression of both CTGF and CYR61 in ROCK-deficient cells (Fig. 5D, E). Here, CCN1 is linked to melanoma.